• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用行政索赔数据估算药物持续性。

Estimating medication persistency using administrative claims data.

作者信息

Sikka Rishi, Xia Fang, Aubert Ronald E

机构信息

Department of Medical Affairs, Medco Health Solutions, Franklin Lakes, NJ 07417, USA.

出版信息

Am J Manag Care. 2005 Jul;11(7):449-57.

PMID:16044982
Abstract

OBJECTIVES

To review the definitions and methods for measuring medication persistency, and to propose a uniform definition of and calculation for persistency using pharmacy claims data.

STUDY DESIGN

Literature review.

METHODS

A MEDLINE search (1966 to present) was performed to identify articles detailing a definition or method of persistency measurement based on automated pharmacy data. Articles were screened for relevance by title and abstract. References from identified articles were used to expand the search results.

RESULTS

The concept behind medication persistency measurement is to capture the amount of time that an individual remains on chronic drug therapy. The methods to calculate medication persistency can be classified into 1 of 3 categories: (1) Persistency as a function of the medication possession ratio; (2) persistency as a function of medication availability at a fixed point in time; and (3) persistency as a function of the gaps between refills.

CONCLUSIONS

The common goal of all persistency measures should be to reflect the continuity of medication usage and to capture the timeliness and the frequency of refilling. The measurement of persistency as a function of the gaps between refills provides the best assessment of refill compliance across a variety of medication and disease states and lends itself to the well-established measurements of survival analysis.

摘要

目的

回顾药物持续性的定义和测量方法,并提出使用药房报销数据对持续性进行统一的定义和计算方法。

研究设计

文献综述。

方法

进行了一次MEDLINE检索(1966年至今),以识别详细阐述基于自动化药房数据的持续性测量定义或方法的文章。通过标题和摘要筛选文章的相关性。利用已识别文章的参考文献来扩展检索结果。

结果

药物持续性测量背后的概念是获取个体接受慢性药物治疗的时长。计算药物持续性的方法可分为以下三类之一:(1)持续性作为药物持有率的函数;(2)持续性作为固定时间点药物可获得性的函数;(3)持续性作为续方间隔的函数。

结论

所有持续性测量的共同目标应是反映药物使用的连续性,并获取续方的及时性和频率。将持续性作为续方间隔的函数进行测量,能对各种药物和疾病状态下的续方依从性提供最佳评估,并且适用于生存分析中成熟的测量方法。

相似文献

1
Estimating medication persistency using administrative claims data.利用行政索赔数据估算药物持续性。
Am J Manag Care. 2005 Jul;11(7):449-57.
2
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.药房管理数据库中依从性的测量:标准定义和首选测量方法的建议
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1280-88. doi: 10.1345/aph.1H018.
3
Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.与索赔数据相比,开角型青光眼护理实践模式的评估:青光眼依从性和持续性研究。
Ophthalmology. 2007 Sep;114(9):1599-606. doi: 10.1016/j.ophtha.2007.03.042. Epub 2007 Jun 18.
4
Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).利用药房报销数据研究青光眼药物治疗的依从性:青光眼依从性和持续性研究(GAPS)的方法与结果
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5052-7. doi: 10.1167/iovs.07-0290.
5
Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization.迈向药物治疗持续性的标准定义与衡量:来自他汀类药物和抗高血压药物使用研究的实例
Clin Ther. 2006 Sep;28(9):1411-24; discussion 1410. doi: 10.1016/j.clinthera.2006.09.021.
6
Comparison of measures of medication persistency using a prescription drug database.
Am Heart J. 2007 Jan;153(1):59-65. doi: 10.1016/j.ahj.2006.10.018.
7
Comparison of various measures for assessing medication refill adherence using prescription data.使用处方数据评估药物续方依从性的各种方法比较。
Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):159-65. doi: 10.1002/pds.1698.
8
A gap analysis approach to assess patient persistence with glaucoma medication.一种用于评估青光眼药物治疗患者依从性的差距分析方法。
Am J Ophthalmol. 2007 Oct;144(4):520-4. doi: 10.1016/j.ajo.2007.06.023. Epub 2007 Aug 9.
9
Measuring patient persistency with drug therapy using methods for the design and analysis of natural history studies.使用自然史研究的设计和分析方法来衡量患者药物治疗的持续性。
Am J Manag Care. 2002 Aug;8(10 Suppl):S249-54.
10
Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy.利用药房数据识别意大利艾米利亚-罗马涅地区的慢性病患者。
J Health Serv Res Policy. 2005 Oct;10(4):232-8. doi: 10.1258/135581905774414259.

引用本文的文献

1
Opioid Exposure Measurement in Postacute Care Under Medicare Consolidated Payments.医疗保险合并支付下急性后期护理中的阿片类药物暴露测量
JAMA Health Forum. 2025 Sep 5;6(9):e253724. doi: 10.1001/jamahealthforum.2025.3724.
2
Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide.描述OPERA队列中的治疗中断情况以及重新使用比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺后的病毒学结果。
AIDS Res Ther. 2025 Jul 21;22(1):71. doi: 10.1186/s12981-025-00769-x.
3
Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis.
杜氏肌营养不良症的真实世界中吗啉代磷酰胺寡聚物治疗模式:基于索赔的分析
J Comp Eff Res. 2025 Aug;14(8):e250037. doi: 10.57264/cer-2025-0037. Epub 2025 Jul 18.
4
Renal safety of Long-Term Non-steroidal Anti-inflammatory drugs use in patients with ankylosing spondylitis.长期使用非甾体抗炎药对强直性脊柱炎患者的肾脏安全性
Sci Rep. 2025 Jul 1;15(1):21066. doi: 10.1038/s41598-025-07146-8.
5
Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World Data.评估转移性肾细胞癌患者对酪氨酸激酶抑制剂的依从性和持续性:真实世界数据的回顾性分析
Clin Med Insights Oncol. 2025 Jun 18;19:11795549251341877. doi: 10.1177/11795549251341877. eCollection 2025.
6
Outpatient care changes and associated mortality among Veterans with heart failure during the COVID-19 pandemic.2019冠状病毒病大流行期间退伍军人心力衰竭患者的门诊护理变化及相关死亡率
PLoS One. 2025 May 16;20(5):e0323308. doi: 10.1371/journal.pone.0323308. eCollection 2025.
7
Establishing a Validation Framework of Treatment Discontinuation in Claims Data Using Natural Language Processing and Electronic Health Records.利用自然语言处理和电子健康记录在索赔数据中建立治疗中断的验证框架。
Clin Pharmacol Ther. 2025 Apr 8. doi: 10.1002/cpt.3650.
8
Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan.低剂量螺内酯联合ACEIs/ARBs可能降低3b-5期慢性肾脏病患者的心血管事件:台湾一项基于全国人群的队列研究
Int J Med Sci. 2025 Feb 24;22(6):1404-1414. doi: 10.7150/ijms.103390. eCollection 2025.
9
Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records.韩国视障人士与非残疾人士在血脂异常药物治疗依从性方面无显著差异:一项使用理赔记录的全国性队列研究。
PLoS One. 2025 Jan 8;20(1):e0307764. doi: 10.1371/journal.pone.0307764. eCollection 2025.
10
Suicidality and use of psychotropic medications in patients with schizophrenia: a prospective cohort study.精神分裂症患者的自杀倾向与精神药物使用:一项前瞻性队列研究。
Psychol Med. 2024 Dec 9;54(16):1-9. doi: 10.1017/S0033291724002873.